1
Harish C Joshi, Keqiang Ye, Judith Kapp, Jaren Landen, David Archer, Cheryl Armstrong, Fuqiang Liu: Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents. Emory University, Bruce D Gray, Kilpatrick Stockton, January 6, 2004: US06673814 (12 worldwide citation)

The present invention relates to methods useful for the treatment of neoplastic diseases, tumor cells, and the treatment of cancer delivering compounds of the formula


2
Keqiang Ye: TRKB agonists and methods of use. Emory University, Emory Patent Group, May 12, 2015: US09029561 (2 worldwide citation)

Compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering a 7,8-dihydroxyflavone derivative with modified flavone or heterocyclic ring to a subject in need thereof. Methods and compounds for the treatment of disorders including neurologic di ...


3
Keqiang Ye: Heterocyclic flavone derivatives, compositions, and methods related thereto. Emory University, Emory Patent Group, March 14, 2017: US09593125 (1 worldwide citation)

In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of 5 treating or preventing diseases or conditio ...


4
Keqiang Ye: TrkB agonists and methods of use. Emory University, Emory Patent Group, November 29, 2016: US09504674 (1 worldwide citation)

Compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering a 7,8-dihydroxyflavone derivative with modified flavone or heterocyclic ring to a subject in need thereof. Methods and compounds for the treatment of disorders including neurologic di ...


5
Keqiang Ye: Neurotrophic activity of deoxygedunin. Emory University, James C Mason, Susanne Hollinger, Emory Patent Group, June 19, 2012: US08203009 (1 worldwide citation)

Novel compounds and methods for activating the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of a compound containing four six-membered rings and a substituted or unsubstituted C5 or C6 heteroaryl or hetero-cycloalkyl ring and ph ...


6
Keqiang Ye: Heterocyclic flavone derivatives, compositions, and methods related thereto. Emory University, Emory Patent Group, July 3, 2018: US10010526

In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diseases or conditions ...


7
Keqiang Ye: Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof. EMORY UNIVERSITY, Emory Patent Group, February 20, 2018: US09895344

Novel compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of 7,8-dihydroxyflavone or derivative thereof. Specifically, methods and compounds for the treatment of disorders includin ...


8
Keqiang Ye: 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto. Emory University, Kilpatrick Townsend & Stockton, May 22, 2018: US09975868

In certain embodiments, the disclosure relates to 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preven ...


9
Keqiang Ye: Methods of managing blood sugar levels and compositions related thereto. EMORY UNIVERSITY, Emory Patent Group, May 26, 2015: US09040713

The disclosure relates to methods of managing blood sugar levels and compositions related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diabetes, insulin resistance, or hyperglycemia comprising administering to a subject diagnosed with, at risk of or ex ...


10
Keqiang Ye: Treating various disorders using TrkB agonists. Emory University, Emory Patent Group, James C Mason, Susanne Hollinger, December 17, 2013: US08609870

Novel compounds and methods for activating the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of a compound containing four six-membered rings and a substituted or unsubstituted C5 or C6 heteroaryl or heterocycloalkyl ring and pha ...